Delivery Order SPE2DB20D2014-SPE2DB25FA17R

Award Date 10/23/24
Potential Completion Date 10/24/24
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA17R
    Delivery Order

This federal contract award, valued at $5,032.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of the pharmaceutical product TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of October 24, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen's extensive federal contract portfolio and status as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, demonstrate the company's critical role in supplying essential medical products to government agencies.

Generated 1/22/25, 9:19 AM